KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Emergent BioSolutions (EBS) Return on Sales: 2010-2025

Historic Return on Sales for Emergent BioSolutions (EBS) over the last 16 years, with Sep 2025 value amounting to 0.10%.

  • Emergent BioSolutions' Return on Sales rose 32.00% to 0.10% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.10%, marking a year-over-year increase of 32.00%. This contributed to the annual value of -0.18% for FY2024, which is 54.00% up from last year.
  • As of Q3 2025, Emergent BioSolutions' Return on Sales stood at 0.10%, which was down 41.27% from 0.16% recorded in Q2 2025.
  • In the past 5 years, Emergent BioSolutions' Return on Sales ranged from a high of 0.22% in Q1 2021 and a low of -0.72% during Q4 2023.
  • For the 3-year period, Emergent BioSolutions' Return on Sales averaged around -0.35%, with its median value being -0.41% (2023).
  • Per our database at Business Quant, Emergent BioSolutions' Return on Sales slumped by 73bps in 2023 and then soared by 82bps in 2025.
  • Quarterly analysis of 5 years shows Emergent BioSolutions' Return on Sales stood at 0.12% in 2021, then tumbled by 32bps to -0.19% in 2022, then plummeted by 53bps to -0.72% in 2023, then skyrocketed by 50bps to -0.23% in 2024, then soared by 32bps to 0.10% in 2025.
  • Its Return on Sales stands at 0.10% for Q3 2025, versus 0.16% for Q2 2025 and -0.17% for Q1 2025.